1

Apparently some testing was conducted; it's mentioned on p. 49 in the MHRA assesment report, albeit not in a lot of detail: Laboratory testing was only conducted in a subgroup of subjects up to 28 days after each dose. The incidence of decreases in white blood cells, neutrophils, and platelets was slightly higher in the AZD1222 group compared with control. ...


Only top voted, non community-wiki answers of a minimum length are eligible